UNSPSC 51152015: Afloqualone

This classification denotes a muscle relaxant with the molecular formula C16H14FN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CO4U2C8ORZ, chemically known as 6-amino-3,4-dihydro-2-fluoromethyl-3-(2-methylphenyl)-4-chinazolinon but generally known as afloqualone, which bears US NIH Compound Identifier 2040. European Medicines Agency schedules Afloqualone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05281MIG.

UNSPSC 51152015 Afloqualone, a Commodity code, shows minimal relevant recent state and local procurement activity. The two opportunities posted under this code in the source do not align with afloqualone — a pharmaceutical compound used to treat specific medical conditions — but instead cover naloxone procurement and pharmacy benefit management services, neither of which falls within the scope of this Commodity classification.

The source documents only exploratory and tangential purchasing signals: Seminole County, Florida issued an IFB on June 30, 2026 for naloxone and drug deactivation systems (1,900 units and 800 systems annually, with a July 26, 2026 response deadline), and the Texas Health and Human Services Commission issued an RFI on April 3, 2026 regarding direct-to-manufacturer prescription fulfillment capabilities. Neither opportunity represents actual afloqualone procurement. State and local governments show no documented recent demand under this code, and procurement professionals should treat this Commodity as inactive pending evidence of genuine market activity.